[Adverse effects of cardiovascular agents].
Tsukada
Yayoi Tetsuou
YT
Department of Internal Medicine, Division of Cardiology, Nippon Medical School.
Kishida
Hiroshi
H
D000638:Amiodarone / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D053840:Brugada Syndrome / Q000139:chemically induced*; D004347:Drug Interactions; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced; D014665:Vasodilator Agents / Q000009:adverse effects*; D014859:Warfarin / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D014859:Warfarin; D006493:Heparin; D000638:Amiodarone